Symbiotics Group, a Switzerland-based impact investing firm, recently launched an independent research firm Tameo, which aims to “promote the growth of the impact investing industry by increasing transparency and supporting evidence-based decision-making via independent solutions.” The new firm will provide investors and investment managers with: (1) impact measurement, labeling, reporting and verification services; (2) the publication of benchmarks, indexes and